Torbay Pharma

Torbay Pharma is a global specialist in the manufacture and supply of terminally sterilized injectables for the secondary care market. They provide fill/finish services for terminally sterilised injectables into plastic and glass vials and ampoules, and their portfolio includes licensed and unlicensed terminally sterilised injectables, electrolyte solutions for total parenteral nutrition (TPN) compounding, and a range of non-sterile oral solutions. Founded in 1975 as part of the Torbay and Devon NHS Foundation Trust, Torbay Pharma has grown into a 250-strong team operating from their purpose-built manufacturing facility in Paignton, UK. In November 2023, the company received investment from NorthEdge Capital and rebranded as Torbay Pharmaceuticals Ltd. Torbay Pharma's strengths lie in their niche product experience and capabilities, agile approach, and a team of experts who genuinely care. They are committed to ensuring quality products are efficiently supplied to the market, with clear communication and consultancy throughout the process. Overall, Torbay Pharma presents an opportunity for investors to engage with a well-established company with a strong track record in the manufacturing and pharmaceutical industries. Their recent Private Equity Round investment at 20 November 2023 by NorthEdge Capital further solidifies their position in the industry. For more information, visit their website: www.torbaypharma.com.